Conversion therapy followed by surgery and adjuvant therapy improves survival in Barcelona C stage hepatocellular carcinoma ― A propensity score-matched analysis
BioScience Trends · 2025
DOI: 10.5582/bst.2025.01162 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioScience Trends, 2025. Verfasst von Yinbiao Cao und 10 weiteren Autor:innen. Beteiligte Einrichtung: First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
- School of Medicine, Nankai University, Tianjin, China.
Zitieren
APA
Cao, Y., Pan, L., Ran, Z., Zhang, W., Li, J., Li, X., Jiao, T., Liu, Z., Wan, T., Tang, H., & Lu, S. (2025). Conversion therapy followed by surgery and adjuvant therapy improves survival in Barcelona C stage hepatocellular carcinoma ― A propensity score-matched analysis. BioScience Trends. https://doi.org/10.5582/bst.2025.01162
Vancouver
Cao Y, Pan L, Ran Z, Zhang W, Li J, Li X, et al. Conversion therapy followed by surgery and adjuvant therapy improves survival in Barcelona C stage hepatocellular carcinoma ― A propensity score-matched analysis. BioScience Trends. 2025. doi:10.5582/bst.2025.01162
BibTeX
@article{Cao2025,
author = {Cao, Yinbiao and Pan, Liru and Ran, Zikun and Zhang, Wenwen and Li, Junfeng and Li, Xuerui and Jiao, Tianyu and Liu, Zhe and Wan, Tao and Tang, Haowen and Lu, Shichun},
title = {Conversion therapy followed by surgery and adjuvant therapy improves survival in Barcelona C stage hepatocellular carcinoma ― A propensity score-matched analysis},
journal = {BioScience Trends},
year = {2025},
doi = {10.5582/bst.2025.01162}
}
EUVIMED